CARISMA THERAPEUTICS INC (CARM) Stock Cash Flow
NASDAQ:CARM - Nasdaq - US14216R1014 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -63.80M | -86.88M | -19.88M | -340.00K | -22.40M | |||
| Depreciation Amortization | 3.40M | 2.84M | 10.00K | 90.00K | 120.00K | |||
| Change In Working Capital | -17.86M | -5.44M | 63.01M | -48.63M | 860.00K | |||
| Interest Paid | 225.00K | 352.00K | N/A | N/A | N/A | |||
| Other non cash items | 10.60M | 8.30M | -18.24M | -20.00M | -9.42M | |||
| OPERATING CASH FLOW | -67.66M | -81.18M | 24.90M | -68.88M | -30.84M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -685.00K | -1.13M | N/A | 0.00 | -10.00K | |||
| Other Investing Activity | 11.00M | 73.54M | -53.97M | N/A | N/A | |||
| INVESTING CASH FLOW | 10.31M | 72.41M | -53.97M | 0.00 | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.04M | -1.19M | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 3.11M | 31.42M | 0.00 | 176.13M | 38.11M | |||
| Other Financing Activity | 3.00K | 31.94M | N/A | 0.00 | N/A | |||
| FINANCING CASH FLOW | 1.06M | 62.18M | 0.00 | 176.13M | 38.11M | |||
| CHANGE IN CASH | -56.28M | 53.41M | -29.07M | 107.25M | 7.26M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -67.66M | -81.18M | 24.90M | -68.88M | -30.84M | |||
| Capital Expenditure | -685.00K | -1.13M | N/A | 0.00 | -10.00K | |||
| FREE CASH FLOW | -68.35M | -82.31M | 24.90M | -68.88M | -30.85M | |||
All data in USD